Welcome to our dedicated page for Amedisys news (Ticker: AMED), a resource for investors and traders seeking the latest updates and insights on Amedisys stock.
Amedisys Inc. (NASDAQ: AMED) is a leading healthcare services company in the United States, specializing in delivering personalized home health, hospice, and high-acuity care services. Headquartered in Baton Rouge, LA, with an executive office in Nashville, TN, the company employs around 18,700 staff across 520 care centers in 37 states and the District of Columbia. Founded in 1982, Amedisys is dedicated to providing quality, clinically-distinctive care to more than 469,000 patients annually, with over 10.6 million visits each year.
Amedisys operates across four key segments: Home Health, Hospice, High Acuity Care, and Personal Care. The Home Health segment offers skilled nursing, therapy, and aid services directly in patients' homes, while the Hospice segment provides end-of-life care to terminally ill patients. The High Acuity Care segment delivers critical inpatient care elements at home, and the Personal Care segment, which was divested in March 2023, offered assistance with daily living activities.
Amedisys's commitment to high-quality care is underpinned by its comprehensive coordination with healthcare providers and personalized care plans tailored to each patient's unique needs. With a strong network involving more than 3,000 hospitals and 110,000 physicians nationwide, Amedisys is a trusted partner in post-acute care.
Recent notable achievements include a merger agreement with UnitedHealth Group, aimed at enhancing patient care through integrated services. Financially, Amedisys reported a net service revenue increase to $571.4 million for Q1 2024, reflecting a robust service demand despite divesting the Personal Care segment.
Additionally, Amedisys is actively involved in advancing healthcare technology. The company has partnered with Patient Choice Laboratories to incorporate advanced molecular testing, enhancing infection diagnosis and patient outcomes. This innovation underscores Amedisys’s commitment to leveraging cutting-edge technology to improve patient care.
For stakeholders, Amedisys remains a prominent figure in the home healthcare industry, constantly adapting and growing to meet the increasing needs of its patient population. The company's strategic partnerships and advancements in healthcare technology position it well for sustained growth and improved patient outcomes.
Amedisys, Inc. (NASDAQ: AMED) announced that its President and CEO, Paul B. Kusserow, will present at the 2020 BMO Prescriptions for Success Healthcare Conference on June 23, 2020, at 1:00 p.m. Eastern Time. Amedisys, a leading home health, hospice, and personal care company, emphasizes personalized care and has partnerships with over 2,600 hospitals and 67,000 physicians. The company serves more than 415,000 patients annually across 39 states and the District of Columbia, employing 22,000 staff in 524 care centers.
Amedisys, a leading home health and hospice company, announced that CEO Paul B. Kusserow will present at the 40th Annual William Blair Growth Stock Conference on June 10, 2020, at 3:00 p.m. Eastern Time. Investors can access the live webcast on the company’s website. Amedisys operates across 39 states, providing personalized care to over 415,000 patients annually. With 22,000 employees and 524 care centers, the company partners with over 2,600 hospitals and 67,000 physicians nationwide, focusing on delivering high-quality home-based healthcare.
Amedisys (NASDAQ: AMED) has completed its acquisition of AseraCare Hospice for $235 million, with a net purchase price of $203 million after accounting for a $32 million tax asset. This acquisition expands Amedisys' hospice services, increasing their care centers to 190 across 35 states and serving approximately 14,000 patients daily. AseraCare, with annual revenues of around $117 million, has 44 locations and employs over 1,200 hospice professionals. Amedisys aims to enhance patient care and reach more communities with this strategic move.
Amedisys, a leading home health and hospice provider, announced that CEO Paul B. Kusserow will present at the 2020 Jefferies Virtual Healthcare Conference on June 2, 2020, at 11:00 a.m. Eastern Time. The presentation can be accessed via a live webcast on Amedisys' investor relations website. Founded in 1982, Amedisys focuses on delivering personalized care to patients across 38 states and the District of Columbia, partnering with over 2,600 hospitals and 67,000 physicians nationwide to provide high-quality home-based care.
Amedisys, Inc. (NASDAQ: AMED) announced that CEO Paul B. Kusserow will present at the RBC Capital Markets 2020 Global Healthcare Conference on May 19, 2020, at 1:20 p.m. ET. Investors can access the live webcast through Amedisys’ website.
Founded in 1982 and headquartered in Baton Rouge, LA, Amedisys is a leading provider of home health, hospice, and personal care services, serving over 415,000 patients annually with a workforce of more than 21,000 employees across 480 care centers in 38 states and the District of Columbia.
Amedisys, Inc. (NASDAQ: AMED) will be presenting at the UBS Global Healthcare Conference 2020 on May 18, 2020, at 3:00 p.m. Eastern Time. Paul B. Kusserow, the President and CEO, will lead the presentation. Investors can access the live webcast on the Amedisys investor relations website. Amedisys is recognized for its home health, hospice, and personal care services, ensuring quality care for over 415,000 patients annually. The company operates 480 care centers across 38 states and the District of Columbia.
Amedisys, Inc. (NASDAQ: AMED) reported a net service revenue of $491.7 million for Q1 2020, an increase of $24.4 million from 2019. Net income rose to $31.8 million, with earnings per share at $0.96. However, adjusted EBITDA decreased to $53.3 million from $54.9 million in 2019. Due to the ongoing COVID-19 pandemic, the company has withdrawn its full-year guidance, citing uncertainty in its financial outlook. Amedisys emphasizes the resilience of its business model and commitment to quality care.
FAQ
What is the current stock price of Amedisys (AMED)?
What is the market cap of Amedisys (AMED)?
What services does Amedisys Inc. provide?
Where is Amedisys Inc. headquartered?
How many employees does Amedisys have?
What is the scope of Amedisys's operations?
How many patients does Amedisys serve annually?
What recent merger has Amedisys entered into?
What recent technological advancement has Amedisys incorporated?
What was Amedisys's net service revenue for Q1 2024?
How does Amedisys coordinate patient care?
What was the Personal Care segment of Amedisys?
